#6
CRISPR Gene Therapy
CRISPR gene therapy has become the definitive curative tool for genetic diseases: Vertex's Casgevy, the first FDA-approved CRISPR treatment, has cured sickle cell patients in 2026, eliminating all pain crises for 18 months post-infusion. Priced at $2.2 million per course, it remains costly, but early access programs have already treated children at no cost.
Photos (1)

Comments on "CRISPR Gene Therapy"
Have a take on this ranking?
Comments are how the argument actually happens here. Posting one needs a free account — it takes about a minute.
No comments yet.
The first comment sets the terms of the argument.